For research use only. Not for therapeutic Use.
microRNA-21-IN-3 (compound 45) can specifically bind to the precursor of oncogenic and pro-inflammatory microRNA-21 with medium nanomolar affinity, reduce cancer cell proliferation and miR-21 levels, and can be used in antitumor research[1].
| Catalog Number | I041151 |
| CAS Number | 2766106-83-4 |
| Synonyms | 2-[(5-piperazin-1-ylpyridin-2-yl)amino]-3H-pyrido[3,4-d]pyrimidin-4-one |
| Molecular Formula | C16H17N7O |
| Purity | ≥95% |
| InChI | InChI=1S/C16H17N7O/c24-15-12-3-4-18-10-13(12)20-16(22-15)21-14-2-1-11(9-19-14)23-7-5-17-6-8-23/h1-4,9-10,17H,5-8H2,(H2,19,20,21,22,24) |
| InChIKey | DLSJIJCYLWIPFC-UHFFFAOYSA-N |
| SMILES | C1CN(CCN1)C2=CN=C(C=C2)NC3=NC4=C(C=CN=C4)C(=O)N3 |
| Reference | [1]. Matthew D Shortridge, et al. Drug-Like Small Molecules That Inhibit Expression of the Oncogenic MicroRNA-21. ACS Chem Biol. 2023 Feb 17;18(2):237-250. |
